Surgical Oncology & Lprscpy - Teaneck, New Jersey 07666

Surgical Oncology & Lprscpy is categorized under Doctors in Teaneck, NJ .

Business Name: Surgical Oncology & Lprscpy
Address: 741 Teaneck Road, Teaneck, New Jersey 07666
Phone Number: (201) 833-2888
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Rosen Lawrence A MD - Teaneck, NJ 07666
Baruch Howard M MD - Teaneck, NJ 07666
Kirzner Howard L MD - Teaneck, NJ 07666
Felman Rina MD - Teaneck, NJ 07666
Kambolis Joanne P MD - Teaneck, NJ 07666
Buchbinder Shalom S MD - Teaneck, NJ 07666
D'Souza Michael MD - Teaneck, NJ 07666
Parker Milford MD - Teaneck, NJ 07666
Ob Gyn Diagnostic's Lab - Teaneck, NJ 07666
Sinensky Gary MD - Teaneck, NJ 07666
Boja III Conrado A MD - Teaneck, NJ 07666
Nunez David A MD - Teaneck, NJ 07666
Women's Welfare Group - Teaneck, NJ 07666
Kronish Anne Louise MD - Teaneck, NJ 07666
Noorily Stuart W MD - Teaneck, NJ 07666
Gorenstein Lyall A MD - Teaneck, NJ 07666
Petrucelli Janet MD - Teaneck, NJ 07666
Feiner Leonard MD - Teaneck, NJ 07666
Aronoff Benjamin W MD - Teaneck, NJ 07666
Schuss Steven A MD - Teaneck, NJ 07666

The company Surgical Oncology & Lprscpy provides B2C services in the form of Doctors from its single location in New Jersey. 1 to 4 employees work for Surgical Oncology & Lprscpy, and the business now earns $500.000 to $999.999 per annum.

Surgical Oncology & Lprscpy was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Surgical Oncology & Lprscpy, please call with the phone number (201) 833-2888 or visit its single location at 741 Teaneck Road in Teaneck, New Jersey 07666.

The location of the single location can also be found using the coordinates 40.883021,-74.008431. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.